Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval

This publication has 17 references indexed in Scilit:

• Clinical assessment of drug-induced QT prolongation in association with heart rate changes
  Clinical Pharmacology & Therapeutics, 2005
• Differences Between Study-Specific and Subject-Specific Heart Rate Corrections of the QT Interval in Investigations of Drug Induced QTc Prolongation
  Pacing and Clinical Electrophysiology, 2004
• Serious ventricular arrhythmias among users of cisapride and other QT‐prolonging agents in the United States
  Pharmacoepidemiology and Drug Safety, 2002
• Drug-Induced QT Prolongation in Women During the Menstrual Cycle
  JAMA, 2001
• The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications Report on a Policy Conference of the European Society of Cardiology
  Cardiovascular Research, 2000
• Heart rate and catecholamine contribution to qt interval shortening on exercise
  Clinical Cardiology, 1999
• An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)
  The American Journal of Cardiology, 1992
• Torsades de pointes occurring in association with terfenadine use
  JAMA, 1990
• Physiologic relation between cardiac cycle and QT duration in healthy volunteers
  The American Journal of Cardiology, 1989
• Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken
  Acta Medica Scandinavica, 1920